Provides design and manufacturing solutions for electromedical devices. Offers design and manufacturing solutions for electromechanical systems. Now — the numbers.
The biggest line carries real weight, but it doesn’t decide everything on its own.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 0.3× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 89% of them.
No analyst target is on record for this company.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
The price looks reasonable next to what the company earns.
This grade is a blend: the profit side is strong, the sales tempo slow.
Clearly below the class average.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
The stock trades 39% below its peak. The market has trimmed its expectations for the company.
Sales run at $118.4M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 16 buys and 2 sells. Management buying with its own money is usually read as a good sign.
A loss of $252K against $118.4M in annual sales. And on top of that, sales fell from the year before.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 43/100.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 46/100. For a turnaround signal, the stock first needs to close the gap with the market.
On our five-subject report card, NSYS sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: NSYS is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Not covered, because the filings we hold do not carry it: earnings execution.